menu
    • menu

    Company profile for MyMD Pharmaceuticals

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    MyMD is a clinical-stage pharmaceutical company focused on the development of drug products that represent a transformation in the targeting of aging and age-related diseases; autoimmune diseases; and chronic pain, anxiety and sleep disorders. Our team has partnered with academic founders and key opinion leaders to identify synthetic therapeutics, including the first drug being designed to significantly increase human lifespan...
    MyMD is a clinical-stage pharmaceutical company focused on the development of drug products that represent a transformation in the targeting of aging and age-related diseases; autoimmune diseases; and chronic pain, anxiety and sleep disorders. Our team has partnered with academic founders and key opinion leaders to identify synthetic therapeutics, including the first drug being designed to significantly increase human lifespan.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MyMD PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    855 N Wolfe St, Ste 623 Baltimore, Maryland 21205
    Telephone
    Telephone
    (813) 864-2566
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.mymd.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    TNF Pharmaceuticals Begins Trading Under New Symbol
    TNF Pharmaceuticals Begins Trading Under New Symbol "TNFA"

    24 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240724213342/en

    BUSINESSWIRE
    24 Jul 2024
    Share Share
    MyMD Pharmaceuticals Rebrands As TNF Pharmaceuticals, Inc
    MyMD Pharmaceuticals Rebrands As TNF Pharmaceuticals, Inc

    22 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240722253499/en

    BUSINESSWIRE
    22 Jul 2024
    Share Share
    MyMD Appoints Mitchell Glass As President And Chief Medical Officer
    MyMD Appoints Mitchell Glass As President And Chief Medical Officer

    17 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240617357457/en

    BUSINESSWIRE
    17 Jun 2024
    Share Share
    MyMD Pharmaceuticals Secures Strategic Investments
    MyMD Pharmaceuticals Secures Strategic Investments

    21 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240521024499/en

    BUSINESSWIRE
    21 May 2024
    Share Share
    MyMD Regains Compliance with Nasdaq Minimum Bid Price Requirement
    MyMD Regains Compliance with Nasdaq Minimum Bid Price Requirement

    05 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240305851820/en

    BUSINESSWIRE
    05 Mar 2024
    Share Share
    MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing
    MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing

    13 Feb 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240213384915/en

    BUSINESSWIRE
    13 Feb 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search